Oleg V. Markov

653 total citations
29 papers, 467 citations indexed

About

Oleg V. Markov is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Oleg V. Markov has authored 29 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Immunology and 4 papers in Oncology. Recurrent topics in Oleg V. Markov's work include RNA Interference and Gene Delivery (21 papers), Immunotherapy and Immune Responses (9 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Oleg V. Markov is often cited by papers focused on RNA Interference and Gene Delivery (21 papers), Immunotherapy and Immune Responses (9 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Oleg V. Markov collaborates with scholars based in Russia, Belarus and Egypt. Oleg V. Markov's co-authors include Н. Л. Миронова, Marina A. Zenkova, Valentin V. Vlassov, М. А. Маслов, Н. Г. Морозова, Elena V. Shmendel, Elena L. Chernolovskaya, Olga Patutina, Aleksandra V. Sen’kova and Irina Yu. Petrushanko and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Oleg V. Markov

26 papers receiving 463 citations

Peers

Countries citing papers authored by Oleg V. Markov

Since Specialization

Citations

This map shows the geographic impact of Oleg V. Markov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oleg V. Markov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oleg V. Markov more than expected).

Fields of papers citing papers by Oleg V. Markov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oleg V. Markov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oleg V. Markov. The network helps show where Oleg V. Markov may publish in the future.

Co-authorship network of co-authors of Oleg V. Markov

This figure shows the co-authorship network connecting the top 25 collaborators of Oleg V. Markov. A scholar is included among the top collaborators of Oleg V. Markov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oleg V. Markov. Oleg V. Markov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The impact of cytokines and tumour‐conditioned medium on the properties of murine in vitro generated myeloid‐derived suppressor cells 2025 ·Scandinavian Journal of Immunology ·Mohammed R. Awad, Aleksandra V. Sen’kova, Marina A. Zenkova, Oleg V. Markov	1
2	A new combination of 5’- and 3’-untranslated regions increases the expression of mRNAs in vitro and in vivo 2025 ·Vavilov Journal of Genetics and Breeding ·(unknown), Oleg V. Markov, (unknown), (unknown), Elena V. Shmendel, (unknown), (unknown), (unknown), М. А. Маслов, Г. А. Степанов	0
3	Soloxolone para-methylanilide effectively suppresses aggressive phenotype of glioblastoma cells including TGF-β1-induced glial-mesenchymal transition in vitro and inhibits growth of U87 glioblastoma xenografts in mice 2024 ·Frontiers in Pharmacology ·(unknown), Aleksandra V. Sen’kova, Oksana V. Salomatina, Oleg V. Markov, Нариман Ф. Салахутдинов, Marina A. Zenkova, Andrey V. Markov	2
4	Novel Efficient Lipid-Based Delivery Systems Enable a Delayed Uptake and Sustained Expression of mRNA in Human Cells and Mouse Tissues 2024 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), (unknown), M. Konopleva, (unknown), (unknown), Elena V. Shmendel, М. А. Маслов, Sergey E. Dmitriev, Г. А. Степанов, Oleg V. Markov	6
5	Influence of Combinations of Lipophilic and Phosphate Backbone Modifications on Cellular Uptake of Modified Oligonucleotides 2024 ·Molecules ·(unknown), Oleg V. Markov, (unknown), С. Н. Ходырева, Maxim S. Kupryushkin	6
6	Extracellular vesicle mimetics as delivery vehicles for oligonucleotide-based therapeutics and plasmid DNA 2024 ·Frontiers in Bioengineering and Biotechnology ·(unknown), Ivan V. Chernikov, С. К. Мирошниченко, Olga Patutina, Oleg V. Markov, Innokenty A. Savin, (unknown), Mariya I. Meschaninova, (unknown), (unknown), Maxim S. Kupryushkin, М. А. Маслов, Aleksandra V. Sen’kova, Valentin V. Vlassov, Elena L. Chernolovskaya, Marina A. Zenkova	2
7	A Comparative Study of Different Protocols for Isolation of Murine Neutrophils from Bone Marrow and Spleen 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Oleg V. Markov, Н. Л. Миронова	7
8	Fork- and Comb-like Lipophilic Structures: Different Chemical Approaches to the Synthesis of Oligonucleotides with Multiple Dodecyl Residues 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Oleg V. Markov, (unknown), С. Н. Ходырева, Maxim S. Kupryushkin	4
9	Bovine Pancreatic RNase A: An Insight into the Mechanism of Antitumor Activity In Vitro and In Vivo 2022 ·Pharmaceutics ·(unknown), Aleksandra V. Sen’kova, Oleg V. Markov, Andrey V. Markov, Innokenty A. Savin, Marina A. Zenkova, Н. Л. Миронова	1
10	Symmetric lipophilic polyamines exhibiting antitumor activity 2022 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Oleg V. Markov, Andrey V. Markov, Ivan V. Chernikov, М. А. Маслов, Marina A. Zenkova	1
11	Immunotherapy Based on Dendritic Cell-Targeted/-Derived Extracellular Vesicles—A Novel Strategy for Enhancement of the Anti-tumor Immune Response 2019 ·Frontiers in Pharmacology ·Oleg V. Markov, (unknown), Н. Л. Миронова	104
12	Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma 2018 ·Science Advances ·А. В. Степанов, Oleg V. Markov, Ivan V. Chernikov, (unknown), Hongkai Zhang, Teresa M. Jones, (unknown), Elena L. Chernolovskaya, Marina A. Zenkova, (unknown), Maria P. Rubtsova, (unknown), Dmitry Genkin, Alexey A. Belogurov, Jia Xie, Alexander G. Gabibov, Richard A. Lerner	21
13	Systemic delivery of complexes of melanoma RNA with mannosylated liposomes activates highly efficient murine melanoma-specific cytotoxic T cells in vivo 2017 ·Molecular Biology ·Oleg V. Markov, Н. Л. Миронова, Elena V. Shmendel, М. А. Маслов, Marina A. Zenkova	9
14	Targeted delivery of nucleic acids into xenograft tumors mediated by novel folate-equipped liposomes 2017 ·European Journal of Pharmaceutics and Biopharmaceutics ·Т. О. Кабилова, Elena V. Shmendel, (unknown), Elena L. Chernolovskaya, Oleg V. Markov, Н. Г. Морозова, М. А. Маслов, Marina A. Zenkova	38
15	СИСТЕМНОЕ ВВЕДЕНИЕ РНК МЕЛАНОМЫ В КОМПЛЕКСЕ С МАННОЗИЛИРОВАННЫМИ ЛИПОСОМАМИ АКТИВИРУЕТ in vivo ВЫСОКОЭФФЕКТИВНЫЕ ЦИТОТОКСИЧЕСКИЕ Т-ЛИМФОЦИТЫ ПРОТИВ МЕЛАНОМЫ МЫШИ, "Молекулярная биология" 2017 ·Молекулярная биология ·Oleg V. Markov, Н. Л. Миронова, Elena V. Shmendel, М. А. Маслов, Marina A. Zenkova	5
16	Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma 2015 ·PLoS ONE ·Oleg V. Markov, Н. Л. Миронова, С. В. Сенников, Valentin V. Vlassov, Marina A. Zenkova	27
17	Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model 2015 ·Journal of Controlled Release ·Oleg V. Markov, Н. Л. Миронова, Elena V. Shmendel, (unknown), Н. Г. Морозова, М. А. Маслов, Valentin V. Vlassov, Marina A. Zenkova	63
18	Ribonuclease binase decreases destructive changes of the liver and restores its regeneration potential in mouse lung carcinoma model 2014 ·Biochimie ·Aleksandra V. Sen’kova, Н. Л. Миронова, Olga Patutina, Vladimir A. Mitkevich, Oleg V. Markov, Irina Yu. Petrushanko, (unknown), Marina A. Zenkova, Alexander А. Makarov	13
19	Ribonuclease binase inhibits primary tumor growth and metastases via apoptosis induction in tumor cells 2013 ·Cell Cycle ·Н. Л. Миронова, Irina Yu. Petrushanko, Olga Patutina, Aleksandra V. Sen’kova, (unknown), Vladimir A. Mitkevich, Oleg V. Markov, Marina A. Zenkova, Alexander А. Makarov	33
20	Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets 2011 ·Journal of Controlled Release ·Oleg V. Markov, Н. Л. Миронова, М. А. Маслов, (unknown), Н. Г. Морозова, Valentin V. Vlassov, Marina A. Zenkova	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact